REPORT COPYRIGHT VIOLATION IN REPLY
|
Message Subject
|
Virus to Mtn., Earth Expnd; 3/5/22 TEC chart; 2022 is gonna be a wild ride!! Midwest out of water!!
|
Poster Handle
|
Anonymous Coward |
Post Content
|
[ link to journals.lww.com (secure)] Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19 Abstract To clarify the effect of aspirin on mortality and viral duration in adults infected with respiratory syndrome coronavirus 2 (SARS-Cov-2). After propensity score-matched (PSM) case-control analyses 24 pairs of patients were enrolled and followed up for 2 months. Both 30-day and 60-day mortality in the aspirin group were significantly lower than that in the non-aspirin group (P = .021 and P = .030, respectively). The viral duration time between the 2 groups was not significantly different (P = .942). Among adults (with hypertension, cardiovascular diseases) infected with SARS-Cov-2, low-dose aspirin medication (100 mg/day) was associated with lower risk of mortality compared with non-aspirin users.
|
|
Please verify you're human:
|
|
Reason for copyright violation:
|